Chronic Thromboembolic Pulmonary Hypertension: the Bedside.

Journal Article (Journal Article;Review)

PURPOSE OF REVIEW: Chronic thromboembolic pulmonary hypertension (CTEPH), included in group 4 PH, is an uncommon complication of acute pulmonary embolism (PE), in which emboli in the pulmonary vasculature do not resolve but rather form into an organized scar-like obstruction which can result in right ventricular (RV) failure. Here we provide an overview of current diagnosis and management of CTEPH. RECENT FINDINGS: CTEPH management is complex with treatments that range from surgery, percutaneous interventions, to medical therapies. Current CTEPH medical therapies have largely been repurposed from pulmonary arterial hypertension (PAH). The diagnosis of CTEPH can be challenging, requiring a multimodality approach to differentiate from disease mimics. While these treatments improve symptoms, they may not reverse the underlying pathology of CTEPH.

Full Text

Duke Authors

Cited Authors

  • Matusov, Y; Singh, I; Yu, Y-R; Chun, HJ; Maron, BA; Tapson, VF; Lewis, MI; Rajagopal, S

Published Date

  • August 19, 2021

Published In

Volume / Issue

  • 23 / 10

Start / End Page

  • 147 -

PubMed ID

  • 34410530

Pubmed Central ID

  • PMC8375459

Electronic International Standard Serial Number (EISSN)

  • 1534-3170

Digital Object Identifier (DOI)

  • 10.1007/s11886-021-01573-5


  • eng

Conference Location

  • United States